Ondine Biomedical, Inc. (OBIMF)
0.25
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Price Chart
Chart unavailable
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.415M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 78.57% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 60.96 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. Its platform technology called antimicrobial photodynamic disinfection to help prevent and help treat infections across many therapeutic areas in healthcare and industry settings. The firm's novel, patented platform technology both reduces inflammation and eliminates harmful pathogens, rapidly destroying bacteria, fungi and viruses including superbugs and SARS-CoV-2. The company was founded by Carolyn Cross on September 9, 1996 and is headquartered in Vancouver, Canada. |
| URL | http://www.ondinebio.com |
| Investor Relations URL | N/A |
| HQ State/Province | British Columbia |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. Its platform technology called antimicrobial photodynamic disinfection to help prevent and help treat infections across many therapeutic areas in healthcare and industry settings. The firm's novel, patented platform technology both reduces inflammation and eliminates harmful pathogens, rapidly destroying bacteria, fungi and viruses including superbugs and SARS-CoV-2. The company was founded by Carolyn Cross on September 9, 1996 and is headquartered in Vancouver, Canada. |
| URL | http://www.ondinebio.com |
| Investor Relations URL | N/A |
| HQ State/Province | British Columbia |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |